Keller F - Search Results

1

Multivariate analysis of aminoglycoside levels in hemodialysis patients.

Kunzendorf U, Keller F, Walz G, Haller H, Offermann G, Borner K, Lode H. Kunzendorf U, et al. Among authors: keller f. Chemotherapy. 1989;35(1):1-6. doi: 10.1159/000238628. Chemotherapy. 1989. PMID: 2721288

2

Elevated tumor markers in hemodialysis patients.

Walz G, Kunzendorf U, Keller F, Fitzner R, Offermann G. Walz G, et al. Among authors: keller f. Am J Nephrol. 1988;8(3):187-9. doi: 10.1159/000167580. Am J Nephrol. 1988. PMID: 2467561

3

Factors influencing the response to hepatitis B vaccination of hemodialysis patients.

Walz G, Kunzendorf U, Haller H, Keller F, Offermann G, Josimovic-Alasevic O, Diamantstein T. Walz G, et al. Among authors: keller f. Nephron. 1989;51(4):474-7. doi: 10.1159/000185379. Nephron. 1989. PMID: 2525677

4

Adjustment of drug dosage to hemodialysis patients.

Keller F, Kunzendorf U, Hilt H, Schwarz A. Keller F, et al. Adv Exp Med Biol. 1989;260:93-103. doi: 10.1007/978-1-4684-5718-6_10. Adv Exp Med Biol. 1989. PMID: 2696374 Review. No abstract available.

5

Aminoglycoside dosage in hemodialysis patients.

Keller F, Wagner K, Borner K, Kemmerich B, Lode H, Offermann G, Distler A. Keller F, et al. J Clin Pharmacol. 1986 Nov-Dec;26(8):690-5. doi: 10.1002/j.1552-4604.1986.tb02974.x. J Clin Pharmacol. 1986. PMID: 3793962

6

Soluble interleukin 2 receptor and tissue polypeptide antigen serum concentrations in end-stage renal failure.

Walz G, Kunzendorf U, Josimovic-Alasevic O, Preuschoff L, Schwarz A, Keller F, Asmus G, Offermann G, Diamantstein T, Distler A. Walz G, et al. Among authors: keller f. Nephron. 1990;56(2):157-61. doi: 10.1159/000186125. Nephron. 1990. PMID: 2243570

7

Slow accumulation of cyclosporin metabolites as measured by specific and nonspecific cyclosporin RIA.

Keller F, Kunzendorf U, Walz G, Schwarz A, Offermann G. Keller F, et al. Int J Clin Pharmacol Ther Toxicol. 1990 Apr;28(4):167-75. Int J Clin Pharmacol Ther Toxicol. 1990. PMID: 2338370

8

Effect of digitoxin on cardiac arrhythmias in hemodialysis patients.

Keller F, Weinmann J, Schwarz A, Andresen D, Haller H, Offermann G, Voehringer HF. Keller F, et al. Klin Wochenschr. 1987 Nov 16;65(22):1081-6. doi: 10.1007/BF01736114. Klin Wochenschr. 1987. PMID: 2447325 Clinical Trial.

9

Cyclosporin drug monitoring: comparison of four immunoassays and HPLC.

Kunzendorf U, Brockmöller J, Jochimsen F, Keller F, Roots I, Walz G, Offermann G. Kunzendorf U, et al. Among authors: keller f. Klin Wochenschr. 1989 Apr 17;67(8):438-41. doi: 10.1007/BF01725139. Klin Wochenschr. 1989. PMID: 2657205

10

Long-term treatment and prognosis of rapidly progressive glomerulonephritis.

Keller F, Oehlenberg B, Kunzendorf U, Schwarz A, Offermann G. Keller F, et al. Clin Nephrol. 1989 Apr;31(4):190-7. Clin Nephrol. 1989. PMID: 2714023

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,137 results

Search Page